Skip to main content
Top
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Magnetic Resonance Imaging | Case report

A rare case report of primary Sjögren’s syndrome with clinical characteristics similar to those of CLIPPERS

Authors: ChenLing Lv, FeiYan Zhu, Chao Chen, YunLing Wang, DengJun Guo, ZhenZhong Zhang

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background

Primary Sjögren’s syndrome (pSS) is an autoimmune inflammatory disease characterized by dryness of the eyes, mouth and other mucous membranes. Patients with pSS can also present with extraglandular manifestations, such as pulmonary, kidney and nervous system involvement. Central nervous system (CNS) manifestations have rarely been described in pSS.

Case presentation

A 33-year-old man was admitted with a one-month history of dizziness, speech disturbance, and walking instability. His brain enhanced magnetic resonance imaging (MRI) showed symmetrical, enhanced “salt-and-pepper-like” speckled lesions in the brainstem, basal ganglia, and subcortical regions, and his diagnosis was considered possible chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Further examination revealed that anti-SSA antibody was positive, and the Schirmer test and labial salivary gland histopathology were abnormal, which supported the diagnosis of pSS.

Conclusion

pSS is a chronic systemic autoimmune disease that involves neurological complications. This case suggests that CNS lesions of pSS can present with clinical and MRI findings similar to those of CLIPPERS.
Literature
1.
go back to reference Margaretten M. Neurologic Manifestations of Primary Sjögren Syndrome. Rheum Dis Clin North Am. 2017;43(4):519–29.CrossRefPubMed Margaretten M. Neurologic Manifestations of Primary Sjögren Syndrome. Rheum Dis Clin North Am. 2017;43(4):519–29.CrossRefPubMed
2.
go back to reference Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine. 2004;83:280–91.CrossRefPubMed Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine. 2004;83:280–91.CrossRefPubMed
3.
go back to reference Moreira I, Teixeira F, Silva AM, et al. Frequent involvement of central nervous system in primary Sjögren syndrome. Rheumatol Int. 2015;35(2):289–94.CrossRefPubMed Moreira I, Teixeira F, Silva AM, et al. Frequent involvement of central nervous system in primary Sjögren syndrome. Rheumatol Int. 2015;35(2):289–94.CrossRefPubMed
4.
go back to reference Pittock SJ, Debruyne J, Krecke KN, et al. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2010;133(9):2626–34.CrossRefPubMed Pittock SJ, Debruyne J, Krecke KN, et al. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2010;133(9):2626–34.CrossRefPubMed
5.
go back to reference Morgen K, McFarland HF, Pillemer SR. Central nervous system disease in primary Sjogrens syndrome: The role of magnetic resonance imaging. Semin Arthritis Rheum. 2004;34(3):623–30.CrossRefPubMed Morgen K, McFarland HF, Pillemer SR. Central nervous system disease in primary Sjogrens syndrome: The role of magnetic resonance imaging. Semin Arthritis Rheum. 2004;34(3):623–30.CrossRefPubMed
6.
go back to reference Yerdelen D, Karatas M, Alkan O, et al. A new kind of and reversible brainstem involvement in primary Sjgren’s syndrome as an initial manifestation. Int J Neurosci. 2010;120(2):155–8.CrossRefPubMed Yerdelen D, Karatas M, Alkan O, et al. A new kind of and reversible brainstem involvement in primary Sjgren’s syndrome as an initial manifestation. Int J Neurosci. 2010;120(2):155–8.CrossRefPubMed
7.
go back to reference Negrini S, Emmi G, Greco M, et al. Sjögren’s syndrome: a systemic autoimmune disease. Clin Exp Med. 2022;22(1):9–25.CrossRefPubMed Negrini S, Emmi G, Greco M, et al. Sjögren’s syndrome: a systemic autoimmune disease. Clin Exp Med. 2022;22(1):9–25.CrossRefPubMed
8.
go back to reference Chivasso C, Sarrand J, Perret J, et al. The involvement of innate and adaptive immunity in the initiation and perpetuation of Sjogren’s syndrome. Int J Mol Sci. 2021;22(2):658.CrossRefPubMedCentral Chivasso C, Sarrand J, Perret J, et al. The involvement of innate and adaptive immunity in the initiation and perpetuation of Sjogren’s syndrome. Int J Mol Sci. 2021;22(2):658.CrossRefPubMedCentral
9.
go back to reference Simon NG, Parratt JD, Barnett MH, et al. Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (clippers). J Neurol Neurosurg Psychiatry. 2012;83(1):15–22.CrossRefPubMed Simon NG, Parratt JD, Barnett MH, et al. Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (clippers). J Neurol Neurosurg Psychiatry. 2012;83(1):15–22.CrossRefPubMed
10.
go back to reference Saigal G, Quencer R. Acute Lacunar Infarcts in CLIPPERS: Is the Chronic Infiltrative Lymphocytic Perivascular Disease Process to Blame? Neuroradiol J. 2013;26(6):629–35.CrossRefPubMedPubMedCentral Saigal G, Quencer R. Acute Lacunar Infarcts in CLIPPERS: Is the Chronic Infiltrative Lymphocytic Perivascular Disease Process to Blame? Neuroradiol J. 2013;26(6):629–35.CrossRefPubMedPubMedCentral
11.
go back to reference Kleinschmidt-Demasters BK, Matthew W. CLIPPERS with chronic small vessel damage: more overlap with small vessel vasculitis. J Neuropathol Exp Neurol. 2014;3:262–7.CrossRef Kleinschmidt-Demasters BK, Matthew W. CLIPPERS with chronic small vessel damage: more overlap with small vessel vasculitis. J Neuropathol Exp Neurol. 2014;3:262–7.CrossRef
12.
go back to reference Blaabjerg M, Ruprecht K, Sinnecker T, et al. Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI. Neurol Neuroimmunol Neuroinflamm. 2016;3(3):e226.CrossRefPubMedPubMedCentral Blaabjerg M, Ruprecht K, Sinnecker T, et al. Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRI. Neurol Neuroimmunol Neuroinflamm. 2016;3(3):e226.CrossRefPubMedPubMedCentral
13.
go back to reference Tobin WO, Guo Y, Krecke KN, et al. Diagnostic criteria for chronic lymphocytic Inflammation with pontine perivascular enhancement responsive to steroids. Brain. 2017;140:2415–25.CrossRefPubMed Tobin WO, Guo Y, Krecke KN, et al. Diagnostic criteria for chronic lymphocytic Inflammation with pontine perivascular enhancement responsive to steroids. Brain. 2017;140:2415–25.CrossRefPubMed
14.
go back to reference Nocturne G, Mariette X. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol. 2015;168(3):317–27.CrossRefPubMed Nocturne G, Mariette X. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol. 2015;168(3):317–27.CrossRefPubMed
15.
16.
go back to reference Hisanori U, Kazuichi O, Yasufumi M, et al. Comprehensive diagnostic criteria for IgG4- related disease (IgG4-RD),2011. Mod Rheumatol. 2012;22(1):21–30.CrossRef Hisanori U, Kazuichi O, Yasufumi M, et al. Comprehensive diagnostic criteria for IgG4- related disease (IgG4-RD),2011. Mod Rheumatol. 2012;22(1):21–30.CrossRef
17.
go back to reference Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/ European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020;72(1):7–19.CrossRefPubMed Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/ European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020;72(1):7–19.CrossRefPubMed
18.
go back to reference Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren’s syndrome A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9–16.CrossRefPubMed Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren’s syndrome A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9–16.CrossRefPubMed
19.
go back to reference Nannini C, Jebakumar AJ, Crowson CS, et al. Primary Sjogren’s syndrome 1976–2005 and associated interstitial lung disease: a population-based study of incidence and mortality. BMJ Open. 2013;3(11):e003569.CrossRefPubMedPubMedCentral Nannini C, Jebakumar AJ, Crowson CS, et al. Primary Sjogren’s syndrome 1976–2005 and associated interstitial lung disease: a population-based study of incidence and mortality. BMJ Open. 2013;3(11):e003569.CrossRefPubMedPubMedCentral
20.
go back to reference Manuel R-C, Brito-Zerón P, Solans R,et al. Systemic involvement in primary Sjogren’s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology. 2014;53(2):321–31.CrossRef Manuel R-C, Brito-Zerón P, Solans R,et al. Systemic involvement in primary Sjogren’s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology. 2014;53(2):321–31.CrossRef
21.
go back to reference Forrester JV, Kuffova L, Dick AD. Autoimmunity, Autoinflammation, and Infection in Uveitis. Am J Ophthalmol. 2018;189:77–85.CrossRefPubMed Forrester JV, Kuffova L, Dick AD. Autoimmunity, Autoinflammation, and Infection in Uveitis. Am J Ophthalmol. 2018;189:77–85.CrossRefPubMed
22.
Metadata
Title
A rare case report of primary Sjögren’s syndrome with clinical characteristics similar to those of CLIPPERS
Authors
ChenLing Lv
FeiYan Zhu
Chao Chen
YunLing Wang
DengJun Guo
ZhenZhong Zhang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02945-2

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue